Interstitial Lung Disease in a Patient Treated with Denosumab

Denosumab is an antiresorptive agent widely used for treating osteoporosis. Atypical femur fractures, osteonecrosis of the jaw and hypocalcaemia are well-known possible adverse effects of this drug. We present, to our knowledge, the first case report in the English literature of clinically significa...

Full description

Bibliographic Details
Main Authors: Ana Campo Ruiz, Miguel F Carrascosa, Sergio Tapia Concha, Anibal Hernández Gil, Juan García Rivero
Format: Article
Language:English
Published: SMC MEDIA SRL 2019-07-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/1131